Mary Lupo, MD, FAAD has joined the US Scientific Advisory Board of Aquavit Pharmaceuticals. Dr. Lupo is a board-certified dermatologist who is internationally recognized for non-surgical skin rejuvenation. In 1984, she opened the Lupo Center for Aesthetic and General Dermatology where she has pioneered the concept of combined therapies such as resurfacing, filler injections, skin care protocols and neuromodulation. She has been a Botox Cosmetic trainer since 2002 and was on the original advisory board for Sculptra Aesthetic in 2003. Additionally, in 2004, she was chosen to be an FDA investigator for Juvederm and participated in the FDA approval for Botox for the treatment of crow's feet. Dr. Lupo was the clinical investigator that launched Juvederm in Australia in 2007.

"We are thrilled to have Dr. Lupo as an advisor. We are one step closer to our mission in personalized medicine with her knowledge and experience," said Sobin Chang, CEO of Aquavit Pharmaceuticals.

Dr. Lupo graduated summa cum laude from Newcomb College of Tulane University in 1976 and completed her internship at Ochsner Foundation Hospital and dermatology residency at Tulane affiliated hospitals. For 30 years, she has acted as Tulane University's Health Science Center. She added cosmetic injectable therapy, sclerotherapy and chemical peels to the core curriculum training for Tulane residents. She is a fellow of the AAD and ASDS for which she served as member of board of directors. Dr. Lupo is a past president of the Women's Dermatological Society and past treasurer of the Louisiana Dermatological Society. Furthermore, she has been named a top doctor by Castle Connelly. Dr. Lupo is a frequent speaker at prestigious facial plastic surgery meetings in the United States such as AAD and ASDS as well as facial plastic surgery meetings abroad. She is joining a stellar line-up of Aquavit's Key Opinion Leaders including Dr. Steven Fagien, Chairman of Global Advisory Board and Dr. David J. Goldberg, Chairman of US Advisory Board.